81 related articles for article (PubMed ID: 10436821)
1. Retinoids in pancreatic cancer.
Riecken EO; Rosewicz S
Ann Oncol; 1999; 10 Suppl 4():197-200. PubMed ID: 10436821
[TBL] [Abstract][Full Text] [Related]
2. The role of specific retinoid receptors in sebocyte growth and differentiation in culture.
Kim MJ; Ciletti N; Michel S; Reichert U; Rosenfield RL
J Invest Dermatol; 2000 Feb; 114(2):349-53. PubMed ID: 10651997
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
5. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines.
Rosewicz S; Stier U; Brembeck F; Kaiser A; Papadimitriou CA; Berdel WE; Wiedenmann B; Riecken EO
Gastroenterology; 1995 Nov; 109(5):1646-60. PubMed ID: 7557150
[TBL] [Abstract][Full Text] [Related]
6. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
7. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
8. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
9. Retinoids: present role and future potential.
Evans TR; Kaye SB
Br J Cancer; 1999 Apr; 80(1-2):1-8. PubMed ID: 10389969
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
11. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
13. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
14. Retinoids, neoplasia and differentiation therapy.
Lippman SM; Davies PJ
Cancer Chemother Biol Response Modif; 1997; 17():349-62. PubMed ID: 9551220
[No Abstract] [Full Text] [Related]
15. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
[TBL] [Abstract][Full Text] [Related]
16. The retinoid receptors.
Pemrick SM; Lucas DA; Grippo JF
Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
[TBL] [Abstract][Full Text] [Related]
17. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
Chen GQ; Lin B; Dawson MI; Zhang XK
Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
[TBL] [Abstract][Full Text] [Related]
18. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model.
El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Apr; 257(2):596-603. PubMed ID: 10198257
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
[TBL] [Abstract][Full Text] [Related]
20. Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog.
Campbell MJ; Park S; Uskokovic MR; Dawson MI; Koeffler HP
Endocrinology; 1998 Apr; 139(4):1972-80. PubMed ID: 9528984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
